Blood最新文献

筛选
英文 中文
Aligning Clinical Trial Reporting: A systematic analysis and position statement by the International Consortium for MDS. 对齐临床试验报告:国际MDS联盟的系统分析和立场声明。
IF 23.9 1区 医学
Blood Pub Date : 2026-11-13 DOI: 10.1182/blood.2026035348
Andrew M Brunner, Ted M Getz, Kelly Pugh, Jan Philipp Bewersdorf, Tariq Kewan, Uma Borate, Amy E DeZern, Uwe Platzbecker, Mikkael A Sekeres, Andrew H Wei, Rena J Buckstein, Gail J Roboz, Michael R Savona, Sanam Loghavi, Robert P Hasserjian, Pierre Fenaux, David A Sallman, Christopher S Hourigan, Matteo Giovanni Della Porta, Stephen D Nimer, Richard F Little, Valeria Santini, Fabio Efficace, Justin Taylor, Olatoyosi Odenike, Tae Kon Kim, Stephanie Halene, Rami S Komrokji, Elizabeth A Griffiths, Peter L Greenberg, Mina L Xu, Zhuoer Xie, Rafael Bejar, Guillermo Sanz, Mrinal M Patnaik, Maria E Figueroa, Hetty E Carraway, Omar Abdel-Wahab, Daniel T Starczynowski, Eric Padron, Jacqueline Boultwood, Steven D Gore, Naval G Daver, Jane E Churpek, John M Bennett, Alan F List, Shahram Kordasti, Adrian Mosquera Orgueira, Klaus H Metzeler, Francesc Sole, Lisa Pleyer, Arjan A van de Loosdrecht, Thomas Cluzeau, David Peter Steensma, Ghulam J Mufti, Lionel Adès, Marie Sebert, Anne Sophie Platzbecker, Yazan F Madanat, R Coleman Lindsley, Katharina S Götze, Carmelo Gurnari, Yasushi Miyazaki, Aref Al-Kali, Abdulraheem Yacoub, Bing Li, Ioannis Kotsianidis, Maximilian Stahl, Amer M Zeidan
{"title":"Aligning Clinical Trial Reporting: A systematic analysis and position statement by the International Consortium for MDS.","authors":"Andrew M Brunner, Ted M Getz, Kelly Pugh, Jan Philipp Bewersdorf, Tariq Kewan, Uma Borate, Amy E DeZern, Uwe Platzbecker, Mikkael A Sekeres, Andrew H Wei, Rena J Buckstein, Gail J Roboz, Michael R Savona, Sanam Loghavi, Robert P Hasserjian, Pierre Fenaux, David A Sallman, Christopher S Hourigan, Matteo Giovanni Della Porta, Stephen D Nimer, Richard F Little, Valeria Santini, Fabio Efficace, Justin Taylor, Olatoyosi Odenike, Tae Kon Kim, Stephanie Halene, Rami S Komrokji, Elizabeth A Griffiths, Peter L Greenberg, Mina L Xu, Zhuoer Xie, Rafael Bejar, Guillermo Sanz, Mrinal M Patnaik, Maria E Figueroa, Hetty E Carraway, Omar Abdel-Wahab, Daniel T Starczynowski, Eric Padron, Jacqueline Boultwood, Steven D Gore, Naval G Daver, Jane E Churpek, John M Bennett, Alan F List, Shahram Kordasti, Adrian Mosquera Orgueira, Klaus H Metzeler, Francesc Sole, Lisa Pleyer, Arjan A van de Loosdrecht, Thomas Cluzeau, David Peter Steensma, Ghulam J Mufti, Lionel Adès, Marie Sebert, Anne Sophie Platzbecker, Yazan F Madanat, R Coleman Lindsley, Katharina S Götze, Carmelo Gurnari, Yasushi Miyazaki, Aref Al-Kali, Abdulraheem Yacoub, Bing Li, Ioannis Kotsianidis, Maximilian Stahl, Amer M Zeidan","doi":"10.1182/blood.2026035348","DOIUrl":"https://doi.org/10.1182/blood.2026035348","url":null,"abstract":"<p><p>Variability in how clinical trial elements are reported can hinder accurate interpretation and comparison of trial results. Here, we systematically analyzed published manuscripts of therapeutic clinical trials in myelodysplastic syndromes/neoplasms (MDS) focusing on how key data elements were reported and made recommendations on how to improve this reporting. We included peer-reviewed full text manuscripts that reported results of clinical trials in MDS and were published between January 1, 2015 to December 31, 2024. We analyzed the presence or absence of several pre-determined key reporting elements and then synthesized these data to evaluate for consistency across manuscripts. We identified substantial variability in descriptions of patient characteristics, as well as the definitions used for response criteria. For example, baseline ANC was reported in only 16% of lower-risk MDS studies and 23% of higher-risk MDS studies, while baseline bone marrow blast percentage was reported in only 55% of higher-risk MDS manuscripts. In addition, response endpoints lacked standardization, with six unique definitions of RBC transfusion independence identified in lower-risk MDS trials and seven different definitions of overall response rate identified in higher-risk MDS trials. Informed by the results of this analysis, we then performed a modified-Delphi process for members of the International Consortium for MDS (icMDS) to develop consensus-based recommendations for consistent and accurate reporting of MDS clinical trial results. We advocate that these recommendations serve as benchmarks and templates for clinical trial reporting in MDS to improve interpretability and comparison of results.</p>","PeriodicalId":9102,"journal":{"name":"Blood","volume":" ","pages":""},"PeriodicalIF":23.9,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fit for the fight: BTK inhibitors prime CAR T cells in CLL 适合战斗:BTK抑制剂激活CLL中的CAR - T细胞
IF 20.3 1区 医学
Blood Pub Date : 2026-11-12 DOI: 10.1182/blood.2026035633
John G. Gribben
{"title":"Fit for the fight: BTK inhibitors prime CAR T cells in CLL","authors":"John G. Gribben","doi":"10.1182/blood.2026035633","DOIUrl":"https://doi.org/10.1182/blood.2026035633","url":null,"abstract":"","PeriodicalId":9102,"journal":{"name":"Blood","volume":"16 1","pages":"2437-2439"},"PeriodicalIF":20.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149397359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathological effects of NETs: seed and soil hypothesis for inflammation spread by primed neutrophils. NETs的病理作用:种子和土壤假说,炎症由引物中性粒细胞传播。
IF 23.9 1区 医学
Blood Pub Date : 2026-11-12 DOI: 10.1182/blood.2026033881
Denisa D Wagner, Lukas A Heger
{"title":"Pathological effects of NETs: seed and soil hypothesis for inflammation spread by primed neutrophils.","authors":"Denisa D Wagner, Lukas A Heger","doi":"10.1182/blood.2026033881","DOIUrl":"10.1182/blood.2026033881","url":null,"abstract":"<p><strong>Abstract: </strong>The ability of activated neutrophils to release decondensed chromatin as neutrophil extracellular traps (NETs) in response to stimuli is conserved throughout evolution. Although NETs support host defense by forming physical barriers against microbes, their toxicity can cause tissue damage. Large NET networks, generated through the activation of NLRP3 inflammasome, the citrullinating enzyme peptidylarginine deiminase 4, and neutrophil-derived enzymes, are central to the pathogenesis of numerous diseases. Chronic disorders often originate at a localized site, for example, the joints in rheumatoid arthritis, or after a major inflammatory event before progressing to distant organs, such as the heart. In this perspective, we hypothesize that circulating primed neutrophils represent the \"seeds\" of chronic disease that adhere to activated vessels, the \"soil\" of susceptible organs. We explore the mechanisms underlying NET formation and discuss animal and human evidence supporting our hypothesis.</p>","PeriodicalId":9102,"journal":{"name":"Blood","volume":" ","pages":"2451-2461"},"PeriodicalIF":23.9,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148879158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paravertebral extramedullary chronic myelomonocytic leukemia mimicking myeloid sarcoma 模拟髓系肉瘤的椎旁髓外慢性髓细胞白血病
IF 20.3 1区 医学
Blood Pub Date : 2026-11-12 DOI: 10.1182/blood.2026035091
Iman Sarami, Carlos E. Bueso-Ramos
{"title":"Paravertebral extramedullary chronic myelomonocytic leukemia mimicking myeloid sarcoma","authors":"Iman Sarami, Carlos E. Bueso-Ramos","doi":"10.1182/blood.2026035091","DOIUrl":"https://doi.org/10.1182/blood.2026035091","url":null,"abstract":"","PeriodicalId":9102,"journal":{"name":"Blood","volume":"12 1","pages":"2551-2551"},"PeriodicalIF":20.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149397354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond provoked and unprovoked: guiding clinical decisions 超越被激怒和非被激怒:指导临床决策
IF 20.3 1区 医学
Blood Pub Date : 2026-11-12 DOI: 10.1182/blood.2026035793
Michael Nagler
{"title":"Beyond provoked and unprovoked: guiding clinical decisions","authors":"Michael Nagler","doi":"10.1182/blood.2026035793","DOIUrl":"https://doi.org/10.1182/blood.2026035793","url":null,"abstract":"","PeriodicalId":9102,"journal":{"name":"Blood","volume":"25 1","pages":"2441-2442"},"PeriodicalIF":20.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149397357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting TMPRSS6 in β-thalassemia: of mice and men 靶向TMPRSS6治疗小鼠和男性β-地中海贫血
IF 20.3 1区 医学
Blood Pub Date : 2026-11-12 DOI: 10.1182/blood.2026034177
Karin E. Finberg
{"title":"Targeting TMPRSS6 in β-thalassemia: of mice and men","authors":"Karin E. Finberg","doi":"10.1182/blood.2026034177","DOIUrl":"https://doi.org/10.1182/blood.2026034177","url":null,"abstract":"","PeriodicalId":9102,"journal":{"name":"Blood","volume":"140 1","pages":"2448-2449"},"PeriodicalIF":20.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149397358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional restoration of immune defects in STAT1 gain-of-function disease after stem cell gene editing. 干细胞基因编辑后STAT1功能获得性疾病免疫缺陷的功能恢复
IF 23.9 1区 医学
Blood Pub Date : 2026-11-12 DOI: 10.1182/blood.2025032242
Robert Torrance, Katharine Orf, Nathan White, Christoph Matti, Alexander J McKenna, Andrea Cosentino, Gabriele Casirati, Adriana S Albuquerque, Adrian J Thrasher, Pietro Genovese, Claire Booth, Thomas A Fox, Siobhan O Burns, Emma C Morris
{"title":"Functional restoration of immune defects in STAT1 gain-of-function disease after stem cell gene editing.","authors":"Robert Torrance, Katharine Orf, Nathan White, Christoph Matti, Alexander J McKenna, Andrea Cosentino, Gabriele Casirati, Adriana S Albuquerque, Adrian J Thrasher, Pietro Genovese, Claire Booth, Thomas A Fox, Siobhan O Burns, Emma C Morris","doi":"10.1182/blood.2025032242","DOIUrl":"10.1182/blood.2025032242","url":null,"abstract":"<p><strong>Abstract: </strong>Germ line gain-of-function (GOF) mutations in the signal transducer and activator of transcription 1 (STAT1) gene cause a dominantly inherited inborn error of immunity (IEI) characterized by chronic mucocutaneous candidiasis, autoimmunity, severe opportunistic infections, and an increased risk of malignancy. Allogeneic hematopoietic stem cell (HSC) transplantation (HSCT) is curative but is associated with increased risk of morbidity and mortality in patients with STAT1 GOF mutations compared with those with other IEIs. To develop a curative, autologous alternative to HSCT, we evaluated gene-editing strategies in STAT1 GOF model cell lines, primary T cells, and patient-derived HSCs. Universal and mutation-specific strategies using CRISPR/Cas-mediated homology-directed repair were limited by low efficacy (<25%), poor viability, and a lack of allele specificity. In contrast, adenine base editing corrected the recurrent and highly pathogenic p.T385M mutation with upwards of 90% efficiency in patient T cells and HSCs without significant unintended on- or off-target genomic aberrations. Gene editing functionally restored total STAT1 expression (P< .0217), STAT1 phosphorylation (P< .0056), interferon-stimulated gene expression (OAS1; P = .0005), and improved interleukin-17 production (P< .0001). Edited HSCs retained multilineage differentiation capacity and sustained engraftment with persistence of the corrected allele at 16 weeks in humanized immunodeficient mice. These data demonstrate efficient and precise correction of STAT1 GOF mutations by base editing, with maintenance of the correction through long-term engraftment in vivo. To our knowledge, this represents the first application of gene editing to correct a dominant GOF mutation causing immunodeficiency, with potential applicability to other genetic disorders associated with heterozygous and GOF mutations.</p>","PeriodicalId":9102,"journal":{"name":"Blood","volume":" ","pages":"2497-2510"},"PeriodicalIF":23.9,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148700720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Masthead Subscription 报头订阅
IF 20.3 1区 医学
Blood Pub Date : 2026-11-12 DOI: 10.1016/s0006-4971(26)11497-9
{"title":"Masthead Subscription","authors":"","doi":"10.1016/s0006-4971(26)11497-9","DOIUrl":"https://doi.org/10.1016/s0006-4971(26)11497-9","url":null,"abstract":"","PeriodicalId":9102,"journal":{"name":"Blood","volume":"12 1","pages":""},"PeriodicalIF":20.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149397353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Et tu, CD70? When friend turns foe for follicular lymphoma CD70呢?当朋友变成滤泡性淋巴瘤的敌人
IF 20.3 1区 医学
Blood Pub Date : 2026-11-12 DOI: 10.1182/blood.2026035585
Claire Roddie, Alexandros Rampotas
{"title":"Et tu, CD70? When friend turns foe for follicular lymphoma","authors":"Claire Roddie, Alexandros Rampotas","doi":"10.1182/blood.2026035585","DOIUrl":"https://doi.org/10.1182/blood.2026035585","url":null,"abstract":"","PeriodicalId":9102,"journal":{"name":"Blood","volume":"22 1","pages":"2444-2446"},"PeriodicalIF":20.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149397355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clone by any other name: convergence of CCUS and LR-MDS 任何其他名称的克隆:CCUS和LR-MDS的融合
IF 20.3 1区 医学
Blood Pub Date : 2026-11-12 DOI: 10.1182/blood.2026035791
Jayanshu Jain, Uma M. Borate
{"title":"A clone by any other name: convergence of CCUS and LR-MDS","authors":"Jayanshu Jain, Uma M. Borate","doi":"10.1182/blood.2026035791","DOIUrl":"https://doi.org/10.1182/blood.2026035791","url":null,"abstract":"","PeriodicalId":9102,"journal":{"name":"Blood","volume":"61 1","pages":"2446-2448"},"PeriodicalIF":20.3,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149397356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书